These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 33378947)

  • 21. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
    Sun L; Cai J; Gonzalez FJ
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between gut bacteria and bile in health and disease.
    Long SL; Gahan CGM; Joyce SA
    Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
    Zhan K; Zheng H; Li J; Wu H; Qin S; Luo L; Huang S
    Biomed Res Int; 2020; 2020():3828249. PubMed ID: 33274207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile Acid Metabolism in Liver Pathobiology.
    Chiang JYL; Ferrell JM
    Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review).
    Luo W; Guo S; Zhou Y; Zhu J; Zhao J; Wang M; Sang L; Wang B; Chang B
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.
    Park MY; Kim SJ; Ko EK; Ahn SH; Seo H; Sung MK
    J Appl Microbiol; 2016 Sep; 121(3):800-10. PubMed ID: 27111464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
    Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
    Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis.
    Cheng SL; Li X; Lehmler HJ; Phillips B; Shen D; Cui JY
    Toxicol Sci; 2018 Dec; 166(2):269-287. PubMed ID: 30496569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
    Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.
    Li CY; Dempsey JL; Wang D; Lee S; Weigel KM; Fei Q; Bhatt DK; Prasad B; Raftery D; Gu H; Cui JY
    Drug Metab Dispos; 2018 Aug; 46(8):1226-1240. PubMed ID: 29769268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
    J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaempferol acts on bile acid signaling and gut microbiota to attenuate the tumor burden in ApcMin/+ mice.
    Li X; Khan I; Huang G; Lu Y; Wang L; Liu Y; Lu L; Hsiao WLW; Liu Z
    Eur J Pharmacol; 2022 Mar; 918():174773. PubMed ID: 35065044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile Acids Activated Receptors Regulate Innate Immunity.
    Fiorucci S; Biagioli M; Zampella A; Distrutti E
    Front Immunol; 2018; 9():1853. PubMed ID: 30150987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome.
    Feng L; Zhang W; Shen Q; Miao C; Chen L; Li Y; Gu X; Fan M; Ma Y; Wang H; Liu X; Zhang X
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1553-1569. PubMed ID: 34585527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.
    Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.
    Golonka RM; Vijay-Kumar M
    Adv Cancer Res; 2021; 149():171-255. PubMed ID: 33579424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.